© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 7, 538-545,
April 4, 2001
© 2001 Oxford University Press
REPORT |
Gender- and Smoking-Related Bladder Cancer Risk
Affiliations of authors: J. E. Castelao, J.-M. Yuan, M. Gago-Dominguez, J. S. Crowder, R. K. Ross, M. C. Yu, University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles; P. L. Skipper, S. R. Tannenbaum, Department of Chemistry and Division of Toxicology, Massachusetts Institute of Technology, Cambridge.
Correspondence to: J. Esteban Castelao, M.D., Ph.D., University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, 1441 Eastlake Ave., Los Angeles, CA 90089-9181 (e-mail: castelao{at}hsc.usc.edu).
Background: There is growing evidence that, when smoking habits are comparable, women incur a higher risk of lung cancer than men. Because smokers are also at risk for bladder cancer, we investigated possible sex differences in the susceptibility to bladder cancer among smokers. Methods: A population-based, case–control study was conducted in Los Angeles, CA, involving 1514 case patients with bladder cancer and 1514 individually matched population control subjects. Information on tobacco use was collected through in-person interviews. Peripheral blood was collected from study participants to measure 3- and 4-aminobiphenyl (ABP)–hemoglobin adducts, a marker of arylamine exposure. Data were analyzed to determine whether the risk of bladder cancer differs between male and female smokers and whether female smokers exhibit higher levels of ABP–hemoglobin adducts than male smokers with comparable smoking habits. All statistical tests were two-sided. Results: Cigarette smokers had a statistically significant 2.5-fold higher risk (95% confidence interval = 2.1 to 3.0) of bladder cancer than never smokers. Use of filtered versus nonfiltered cigarettes, low-tar versus higher tar cigarettes, or the pattern of inhalation did not modify the risk. The risk of bladder cancer in women who smoked was statistically significantly higher than that in men who smoked comparable numbers of cigarettes (P = .016 for sex–lifetime smoking interaction). Consistent with the sex difference in smoking-related bladder cancer risk, the slopes of the linear regression lines of the 3- and 4-ABP–hemoglobin adducts by cigarettes per day were statistically significantly steeper in women than in men (P values for sex differences <.001 and .006, respectively). Conclusion: The risk of bladder cancer may be higher in women than in men who smoked comparable amounts of cigarettes.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Baris, M. R. Karagas, C. Verrill, A. Johnson, A. S. Andrew, C. J. Marsit, M. Schwenn, J. S. Colt, S. Cherala, C. Samanic, et al. A Case-Control Study of Smoking and Bladder Cancer Risk: Emergent Patterns Over Time J Natl Cancer Inst, November 18, 2009; 101(22): 1553 - 1561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Stern, D. Van Den Berg, J.-M. Yuan, D. V. Conti, M. Gago-Dominguez, M. C. Pike, Y.-B. Xiang, Y.-T. Gao, and V. K. Cortessis Sequence Variant on 3q28 and Urinary Bladder Cancer Risk: Findings from the Los Angeles-Shanghai Bladder Case-Control Study Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 3057 - 3061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Stern, J. Lin, J. D. Figueroa, K. T. Kelsey, A. E. Kiltie, J.-M. Yuan, G. Matullo, T. Fletcher, S. Benhamou, J. A. Taylor, et al. Polymorphisms in DNA Repair Genes, Smoking, and Bladder Cancer Risk: Findings from the International Consortium of Bladder Cancer Cancer Res., September 1, 2009; 69(17): 6857 - 6864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Horiuchi, M. Washio, C. Kiyohara, H. Tsukamoto, Y. Tada, T. Asami, S. Ide, G. Kobashi, H. Takahashi, and the Kyushu Sapporo SLE Study Group Combination of TNF-RII, CYP1A1 and GSTM1 polymorphisms and the risk of Japanese SLE: findings from the KYSS study Rheumatology, September 1, 2009; 48(9): 1045 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Wolff, G. Liang, C. C. Cortez, Y. C. Tsai, J. E. Castelao, V. K. Cortessis, D. D. Tsao-Wei, S. Groshen, and P. A. Jones RUNX3 Methylation Reveals that Bladder Tumors Are Older in Patients with a History of Smoking Cancer Res., August 1, 2008; 68(15): 6208 - 6214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Yuan, K. K. Chan, G. A. Coetzee, J.E. Castelao, M. A. Watson, D. A. Bell, R. Wang, and M. C. Yu Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer Carcinogenesis, July 1, 2008; 29(7): 1386 - 1393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tang, G. R. Zirpoli, K. Guru, K. B. Moysich, Y. Zhang, C. B. Ambrosone, and S. E. McCann Consumption of Raw Cruciferous Vegetables is Inversely Associated with Bladder Cancer Risk Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 938 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Teng, Z.-Y. Wang, D. F Jarrard, and D. E Bjorling Roles of estrogen receptor {alpha} and {beta} in modulating urothelial cell proliferation Endocr. Relat. Cancer, March 1, 2008; 15(1): 351 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wu, J. Lin, H. B. Grossman, M. Huang, J. Gu, C. J. Etzel, C. I. Amos, C. P. Dinney, and M. R. Spitz Projecting Individualized Probabilities of Developing Bladder Cancer in White Individuals J. Clin. Oncol., November 1, 2007; 25(31): 4974 - 4981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Jiang, J.-M. Yuan, P. L. Skipper, S. R. Tannenbaum, and M. C. Yu Environmental Tobacco Smoke and Bladder Cancer Risk in Never Smokers of Los Angeles County Cancer Res., August 1, 2007; 67(15): 7540 - 7545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhu, M. Lai, H. Yang, J. Lin, M. Huang, H.B. Grossman, C. P. Dinney, and X. Wu Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer Carcinogenesis, March 1, 2007; 28(3): 698 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Samanic, M. Kogevinas, M. Dosemeci, N. Malats, F. X. Real, M. Garcia-Closas, C. Serra, A. Carrato, R. Garcia-Closas, M. Sala, et al. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1348 - 1354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. McGrath, D. S. Michaud, and I. De Vivo Hormonal and Reproductive Factors and the Risk of Bladder Cancer in Women Am. J. Epidemiol., February 1, 2006; 163(3): 236 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Airoldi, P. Vineis, A. Colombi, L. Olgiati, C. Dell'Osta, R. Fanelli, L. Manzi, F. Veglia, H. Autrup, A. Dunning, et al. 4-Aminobiphenyl-Hemoglobin Adducts and Risk of Smoking-Related Disease in Never Smokers and Former Smokers in the European Prospective Investigation into Cancer and Nutrition Prospective Study Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2118 - 2124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Schabath, G. L. Delclos, H. B. Grossman, Y. Wang, S. P. Lerner, R. M. Chamberlain, M. R. Spitz, and X. Wu Polymorphisms in XPD Exons 10 and 23 and Bladder Cancer Risk Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 878 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gan, P. L. Skipper, M. Gago-Dominguez, K. Arakawa, R. K. Ross, M. C. Yu, and S. R. Tannenbaum Alkylaniline-Hemoglobin Adducts and Risk of Non-Smoking-Related Bladder Cancer J Natl Cancer Inst, October 6, 2004; 96(19): 1425 - 1431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. K. Cortessis, K. Siegmund, S. Xue, R. K. Ross, and M. C. Yu A case-control study of cyclin D1 CCND1 870A->G polymorphism and bladder cancer Carcinogenesis, October 1, 2003; 24(10): 1645 - 1650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tsuneoka, T. P. Dalton, M. L. Miller, C. D. Clay, H. G. Shertzer, G. Talaska, M. Medvedovic, and D. W. Nebert 4-Aminobiphenyl-Induced Liver and Urinary Bladder DNA Adduct Formation in Cyp1a2(-/-) and Cyp1a2(+/+) Mice J Natl Cancer Inst, August 20, 2003; 95(16): 1227 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Skipper, S. R. Tannenbaum, R. K. Ross, and M. C. Yu Nonsmoking-related Arylamine Exposure and Bladder Cancer Risk Cancer Epidemiol. Biomarkers Prev., June 1, 2003; 12(6): 503 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Mandola, J. Stoehlmacher, S. Muller-Weeks, G. Cesarone, M. C. Yu, H.-J. Lenz, and R. D. Ladner A Novel Single Nucleotide Polymorphism within the 5' Tandem Repeat Polymorphism of the Thymidylate Synthase Gene Abolishes USF-1 Binding and Alters Transcriptional Activity Cancer Res., June 1, 2003; 63(11): 2898 - 2904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gago-Dominguez, D. A. Bell, M. A. Watson, J.-M. Yuan, J.E. Castelao, D. W. Hein, K. K. Chan, G. A. Coetzee, R. K. Ross, and M. C. Yu Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2 Carcinogenesis, March 1, 2003; 24(3): 483 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Carmella, M. Chen, P. W. Villalta, J. G. Gurney, D. K. Hatsukami, and S. S. Hecht Ethylation and methylation of hemoglobin in smokers and non-smokers Carcinogenesis, November 1, 2002; 23(11): 1903 - 1910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Engel, E. Taioli, R. Pfeiffer, M. Garcia-Closas, P. M. Marcus, Q. Lan, P. Boffetta, P. Vineis, H. Autrup, D. A. Bell, et al. Pooled Analysis and Meta-analysis of Glutathione S-Transferase M1 and Bladder Cancer: A HuGE Review Am. J. Epidemiol., July 15, 2002; 156(2): 95 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Meisel Cancer, genes and gender Carcinogenesis, June 1, 2002; 23(6): 1087 - 1088. [Full Text] [PDF]
|
|
|
|
|
|
K. Conway, S. N. Edmiston, L. Cui, S. S. Drouin, J. Pang, M. He, C.-K. Tse, J. Geradts, L. Dressler, E. T. Liu, et al. Prevalence and Spectrum of p53 Mutations Associated with Smoking in Breast Cancer Cancer Res., April 1, 2002; 62(7): 1987 - 1995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. V. Perneger RESPONSE: Re: Sex, Smoking, and Cancer: a Reappraisal J Natl Cancer Inst, February 20, 2002; 94(4): 309 - 310. [Full Text] [PDF]
|
|
|
|
|
|
E. A. Zang Re: Sex, Smoking, and Cancer: a Reappraisal J Natl Cancer Inst, February 20, 2002; 94(4): 308 - 309. [Full Text] [PDF]
|
|
|
|
|
|
T. V. Perneger Sex, Smoking, and Cancer: a Reappraisal J Natl Cancer Inst, November 7, 2001; 93(21): 1600 - 1602. [Full Text] [PDF]
|
|